University of Washington trial testing Rylaze in adult ALL is suspended for safety reviewSep 29Trial updateasparaginase erwinia chrysanthemi (recombinant)-rywnJazz Pharmaceuticals
Loxo posts Phase 3 pirtobrutinib results; five more Lilly-linked trials updateSep 25Weekly roundup, 6 itemsabemaciclibbrenipatide
Rocket Pharmaceuticals says FDA aligns on Danon disease pivotal trial pathSep 15Clinical readoutRocket Pharmaceuticals, Inc.
Fate Therapeutics registers Phase 1/2 trial of FT839 across five autoimmune diseasesSep 2Trial updateFate TherapeuticsFT839
Roche's glofitamab Phase 2 trial in untreated DLBCL posts results after primary completionAug 18Trial updateglofitamabprednisone
Cellectar registers Phase 3 trial comparing iopofosine I 131 to R-CD in Waldenstrom'sAug 14Trial updateCellectar Biosciences, Inc.
Artiva reports Q2 2026 results, RMAT for AlloNK in refractory RA, Phase 3 planAug 6Quarterly updateArtiva Biotherapeutics, Inc.
BeOne Medicines reports Q2 2026 results, raises full-year revenue guidanceAug 5Quarterly updateBeiGenesonrotoclax
AbbVie to acquire Apogee Therapeutics, updates 2026 EPS guidance amid Q2 resultsJul 31Quarterly updateAbbVie
Trial registered for tafasitamab plus rituximab in newly diagnosed follicular lymphomaJul 28Trial updateIncyte Corporationrituximab
Sign inSign in